Cargando…

Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain

BACKGROUND: Updated seroprevalence estimates are important to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) landscape and to guide public health decisions. The aims are to describe longitudinal changes in seroprevalence in children in a region in Northern Spain and to ana...

Descripción completa

Detalles Bibliográficos
Autores principales: García-García, Elisa, Rodríguez-Pérez, Mercedes, Pérez-Solís, David, Pérez-Méndez, Carlos, Molinos-Norniella, Cristina, Cobo-Ruisánchez, Ángeles, Fernández Fernández, Eva María, González, Noelia García, Calle-Miguel, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514983/
https://www.ncbi.nlm.nih.gov/pubmed/36169886
http://dx.doi.org/10.1007/s12519-022-00617-2
_version_ 1784798391766614016
author García-García, Elisa
Rodríguez-Pérez, Mercedes
Pérez-Solís, David
Pérez-Méndez, Carlos
Molinos-Norniella, Cristina
Cobo-Ruisánchez, Ángeles
Fernández Fernández, Eva María
González, Noelia García
Calle-Miguel, Laura
author_facet García-García, Elisa
Rodríguez-Pérez, Mercedes
Pérez-Solís, David
Pérez-Méndez, Carlos
Molinos-Norniella, Cristina
Cobo-Ruisánchez, Ángeles
Fernández Fernández, Eva María
González, Noelia García
Calle-Miguel, Laura
author_sort García-García, Elisa
collection PubMed
description BACKGROUND: Updated seroprevalence estimates are important to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) landscape and to guide public health decisions. The aims are to describe longitudinal changes in seroprevalence in children in a region in Northern Spain and to analyze factors associated with SARS-CoV-2 seropositivity. METHODS: Prospective multicenter longitudinal study with subjects recruited from July to September 2020. Children (up to 14 years old) were included and followed up until September 2021. Venous blood samples were collected every six months during three testing rounds and were analyzed for SARS-CoV-2 antibodies. The data regarding epidemiological features, contact tracing, symptoms, and virological tests were collected. The evolution of SARS-CoV-2 seroprevalence during the study and the differences between children with positive and negative SARS-CoV-2 antibody tests were analyzed. RESULTS: Two hundred children were recruited (50.5% girls, median age 9.7 years). The overall seroprevalence increased from round 1 [1.5%, 95% confidence interval (CI) 0.3%–4.3%] to round 2 (9.1%, 95% CI 4.6%–12.7%) and round 3 (16.6%, 95% CI 9.5%–19.6%) (P < 0.001). Main changes occurred in children aged zero to four years (P = 0.001) who lived in urban areas (P < 0.001). None of the children who were previously positive became seronegative. Following multivariable analysis, three variables independently associated with SARS-CoV-2 seropositivity were identified: close contact with coronavirus disease 2019 (COVID-19) confirmed or suspected cases [odds ratio (OR) = 3.9, 95% CI 1.2–12.5], previous positive virological test (OR = 17.1, 95% CI 3.7–78.3) and fatigue (OR = 18.1, 95% CI 1.7–193.4). CONCLUSIONS: SARS-CoV-2 seroprevalence in children has remarkably increased during the time of our study. Fatigue was the only COVID-19-compatible symptom that was more frequent in seropositive than in seronegative children.
format Online
Article
Text
id pubmed-9514983
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-95149832022-09-28 Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain García-García, Elisa Rodríguez-Pérez, Mercedes Pérez-Solís, David Pérez-Méndez, Carlos Molinos-Norniella, Cristina Cobo-Ruisánchez, Ángeles Fernández Fernández, Eva María González, Noelia García Calle-Miguel, Laura World J Pediatr Original Article BACKGROUND: Updated seroprevalence estimates are important to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) landscape and to guide public health decisions. The aims are to describe longitudinal changes in seroprevalence in children in a region in Northern Spain and to analyze factors associated with SARS-CoV-2 seropositivity. METHODS: Prospective multicenter longitudinal study with subjects recruited from July to September 2020. Children (up to 14 years old) were included and followed up until September 2021. Venous blood samples were collected every six months during three testing rounds and were analyzed for SARS-CoV-2 antibodies. The data regarding epidemiological features, contact tracing, symptoms, and virological tests were collected. The evolution of SARS-CoV-2 seroprevalence during the study and the differences between children with positive and negative SARS-CoV-2 antibody tests were analyzed. RESULTS: Two hundred children were recruited (50.5% girls, median age 9.7 years). The overall seroprevalence increased from round 1 [1.5%, 95% confidence interval (CI) 0.3%–4.3%] to round 2 (9.1%, 95% CI 4.6%–12.7%) and round 3 (16.6%, 95% CI 9.5%–19.6%) (P < 0.001). Main changes occurred in children aged zero to four years (P = 0.001) who lived in urban areas (P < 0.001). None of the children who were previously positive became seronegative. Following multivariable analysis, three variables independently associated with SARS-CoV-2 seropositivity were identified: close contact with coronavirus disease 2019 (COVID-19) confirmed or suspected cases [odds ratio (OR) = 3.9, 95% CI 1.2–12.5], previous positive virological test (OR = 17.1, 95% CI 3.7–78.3) and fatigue (OR = 18.1, 95% CI 1.7–193.4). CONCLUSIONS: SARS-CoV-2 seroprevalence in children has remarkably increased during the time of our study. Fatigue was the only COVID-19-compatible symptom that was more frequent in seropositive than in seronegative children. Springer Nature Singapore 2022-09-28 2022 /pmc/articles/PMC9514983/ /pubmed/36169886 http://dx.doi.org/10.1007/s12519-022-00617-2 Text en © Children's Hospital, Zhejiang University School of Medicine 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
García-García, Elisa
Rodríguez-Pérez, Mercedes
Pérez-Solís, David
Pérez-Méndez, Carlos
Molinos-Norniella, Cristina
Cobo-Ruisánchez, Ángeles
Fernández Fernández, Eva María
González, Noelia García
Calle-Miguel, Laura
Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
title Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
title_full Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
title_fullStr Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
title_full_unstemmed Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
title_short Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
title_sort variation in sars-cov-2 seroprevalence in children in the region of asturias, northern spain
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514983/
https://www.ncbi.nlm.nih.gov/pubmed/36169886
http://dx.doi.org/10.1007/s12519-022-00617-2
work_keys_str_mv AT garciagarciaelisa variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT rodriguezperezmercedes variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT perezsolisdavid variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT perezmendezcarlos variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT molinosnorniellacristina variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT coboruisanchezangeles variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT fernandezfernandezevamaria variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT gonzaleznoeliagarcia variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain
AT callemiguellaura variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain